Table 2.
Comparison of patients with and without pneumococcal vaccination
| Pneumococcal vaccination (+) (n=63) |
Pneumococcal vaccination (–) (n=79) |
P | |
| Age, years | 76 (65–91) | 76 (66–99) | 0.990 |
| Sex (female:male) | 33:30 | 31:48 | 0.130 |
| Smoking history (never/past+current) | 31/32 | 31/48 | 0.307 |
| Comorbidities | |||
| Chronic respiratory disease | 26 (41.3%) | 9 (11.5%) | <0.001 |
| Cardiovascular disease | 15 (23.8%) | 12 (15.2%) | 0.205 |
| Collagen vascular disease | 1 (1.6%) | 4 (5.1%) | 0.382 |
| Diabetes | 11 (17.5%) | 13 (16.5%) | 1.000 |
| Active malignancy | 3 (4.8%) | 2 (2.5%) | 0.655 |
| Regularly visiting clinics and/or hospitals for: | |||
| Any disease | 56 (88.9%) | 71 (89.9%) | 1.000 |
| Internal disease | 51 (81%) | 67 (84.8%) | 0.653 |
| Use of systemic steroid and/or immunosuppressant | 0 (0%) | 5 (6.3%) | 0.066 |
| Receipt of PPSV23 notice from municipality | 59 (93.7%) | 51 (64.6%) | <0.001 |
| Reason for visiting our hospital
(radiographic abnormality a) |
26 (41.3%) | 36 (45.6%) | 0.615 |
Data are presented as median (range) or number of patients (%).
a From annual lung cancer screening or medical check